cyclosporine has been researched along with Acute Respiratory Distress Syndrome in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G | 1 |
Bach, JF; Evans, NA; Manchester, AC; Walker, JM | 1 |
Long, A; Marik, PE | 1 |
Goto, M; Kakihana, Y; Kawano, Y; Kodama, Y; Nishikawa, T; Okamoto, Y; Shinkoda, Y; Tanabe, T | 1 |
Gewitz, MH; Huang, J; Katta, US; Krishnan, U; Mathew, R; Sandoval, C | 1 |
Gugger, M; Guglielmi, S; Merz, TM; Nicod, LP; Suter, C | 1 |
Hirabayashi, N; Ikeda, Y; Ishida, A; Matsuoka, S; Moriki, T; Okamoto, S; Wakui, M; Watanabe, R | 1 |
Castagnola, C; Corso, A; Nascimbene, C; Vitulo, P; Volpini, E; Zappasodi, P | 1 |
8 other study(ies) available for cyclosporine and Acute Respiratory Distress Syndrome
Article | Year |
---|---|
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine | 2020 |
Acute respiratory distress syndrome and septic shock in a cat with disseminated toxoplasmosis.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clindamycin; Cyclosporine; Fatal Outcome; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Parasitic; Male; Oxygen; Respiratory Distress Syndrome; Shock, Septic; Toxoplasmosis, Animal | 2017 |
ARDS complicating pustular psoriasis: treatment with low-dose corticosteroids, vitamin C and thiamine.
Topics: Adrenal Cortex Hormones; Continuous Positive Airway Pressure; Critical Illness; Cyclosporine; Drug Therapy, Combination; Electrocardiography; Female; Humans; Immunosuppressive Agents; Middle Aged; Psoriasis; Radiography; Respiratory Distress Syndrome; Severity of Illness Index | 2018 |
Acute respiratory distress syndrome as an initial presentation of hemophagocytic lymphohistiocytosis after induction therapy for acute myeloid leukemia.
Topics: Antineoplastic Agents; Bone Marrow; Cyclosporine; Fatal Outcome; Female; Ferritins; Humans; Infant, Newborn; Leukemia, Myeloid, Acute; Lymphohistiocytosis, Hemophagocytic; Prognosis; Receptors, Interleukin-2; Respiratory Distress Syndrome | 2011 |
Immunosuppressant-induced endothelial damage and pulmonary arterial hypertension.
Topics: Child, Preschool; Cyclosporine; Endothelium, Vascular; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Infant; Male; Respiratory Distress Syndrome; Risk Factors | 2011 |
Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus.
Topics: Antibodies, Antinuclear; Autoantibodies; CD8-Positive T-Lymphocytes; Cyclosporine; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Polymyositis; Respiratory Distress Syndrome; Syndrome; Tacrolimus; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
[Severe hepatic veno-occlusive disease (VOD) which was successfully treated with supportive therapy, but subsequently developed late-recurrence].
Topics: Adult; Bone Marrow Transplantation; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Recurrence; Respiratory Distress Syndrome; Tacrolimus | 1998 |
Successful therapy with high-dose steroids and cyclosporine for the treatment of carmustine-mediated lung injury.
Topics: Adult; Antineoplastic Agents, Alkylating; Carmustine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Methylprednisolone; Respiratory Distress Syndrome | 2002 |